Postoperative PINP in serum reflects metastatic potential and poor survival in node-positive breast cancer

Anticancer Research

Volumn 21, Issue 4 B, 2001, Pages 2873-2876

  Jukkola, A ^a   Bloigu, R ^a   Holli, K ^a   Joensuu, H ^a   Valavaara, R ^a   Risteli, J ^a   Blanco, G ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Breast cancer; Metastasis; Type I collagen

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 1 AMINOTERMINAL PROPEPTIDE; COLLAGEN TYPE 1 CARBOXYTERMINAL PROPEPTIDE; COLLAGEN TYPE 1 CARBOXYTERMINAL TELOPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS, HORMONAL; BONE NEOPLASMS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; EXTRACELLULAR MATRIX; FINLAND; FOLLOW-UP STUDIES; LYMPHATIC METASTASIS; MASTECTOMY; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, PROGESTERONE; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS; TAMOXIFEN; TOREMIFENE; TUMOR MARKERS, BIOLOGICAL;

EID: 0035162152     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value comparison with nodal status
2. Reduction in new metastases in breast cancer with adjuvant clodronate treatment
3. American Society of Clinical Oncology guideline on the role of biphosphonates in breast cancer
4. Collagen family of proteins
5. Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma
6. Type I collagen degradation product (ICTP) gives information about the nature of bone metastasis and has prognostic value in prostate cancer
7. Dissociation of bone formation markers in bone metastases of prostate cancer
8. Usefulness of bone metabolic markers in the diagnosis and follow-up of bone metastasis from lung cancer
9. Serum type I collagen degradation markers, ICTP and cross-laps are factors for poor survival in lung cancer
10. Elevated serum ICTP concentrations reflect poor prognosis in patients with ovarian carcinoma
11. Type I and type III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer
12. Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer
13. Radioimmunoassay for the pyridoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation
14. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen
15. Immunoassay for intact aminoterminal propeptide of type I procollagen
16. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I carboxy-and aminoterminal propeptides (PINP, PICP) as markers of metastatic bone disease in breast cancer
17. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma
18. Aggressive breast cancer leads to discrepant serum levels of the type I procollagen
19. Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis
20. Bone sialo-protein in primary human breast cancer is associated with bone metastases development